Article ID Journal Published Year Pages File Type
2161111 Radiotherapy and Oncology 2007 8 Pages PDF
Abstract
In case of PSAf after RRP, VUBx before SalvRT seems unnecessary for PSA ⩽ 0.9 ng/mL. For higher values, a positive VUBx seems to always justify a SalvRT, which may not be recommendable, given the nonnegligible risk of an already micrometastatic disease, if the biopsy results are negative.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , , , , ,